Upcoming events

2021

May

25

ABGSC Life Science Summit Add to calendar

June

02

Redeye growth day Add to calendar

June

03

Erik Penser bank bolagsdag Add to calendar

August

25

Handelsbanken life science innovation seminar Add to calendar

Corporate presentation, May 11 2021

CEO, Carl-Johan Dalsgaard gives an update on Vicore's operations for the virtual AGM.

Company presentation

Vicore Pharma company presentation, May 2021

Download PDF

Previous presentations

DTx webinar, May 4 2021

Presentation on the digital therapeutic (DTx) program.

KOL webinar on COVID-19, April 28 2021

Presentation by KOL Professor Maureen Horton, M.D., Johns Hopkins University School of Medicine on the current treatment landscape and unmet medical needs in treating patients with COVID-19. Update on the results from Vicore's phase II study in COVID-19 and the coming phase III pivotal study.

Redeye interview, March 30 2021

Interview with CEO Carl-Johan Dalsgaard on the results from the phase II mechanistic study in systemic sclerosis (in Swedish).

Pareto interview, March 22 2021

Interview with CEO, Carl-Johan Dalsgaard on the results from the phase II mechanistic study in systemic sclerosis and the coming phase III study in COVID-19

Webcast presentation, Dec 21 2020

Presentation of expanded results from the phase II trial in COVID-19.

Redeye interview, Dec 11 2020

Interview with Carl-Johan Dalsgaard on COVID-19 top line data.

Webcast presentation, Dec 8 2020

Presentation of top line data from the phase II trial in COVID-19.

Stora aktiedagen, Nov 10 2020

CFO, Hans Jeppsson presented Vicore Pharma at Stora Aktiedagen in Gothenburg.

Pareto Securities Healthcare Conference, Sep 5 2020

Interview with CEO, Carl-Johan Dalsgaard during Pareto Securities Healthcare Conference.

Webcast presentations, Jun 3 2020

CEO, Carl-Johan Dalsgaard presented Vicore Pharma at Avanza digitala börsdag.

Webcast presentation, Apr 28 2020

CEO, Carl-Johan Dalsgaard presented the approved upcoming phase II study with VP01 in COVID-19.

Pareto Securities, Apr 17 2020

Interview with CEO, Carl-Johan Dalsgaard (Swedish)

Webcast presentation, Mar 31 2020

CEO, Carl-Johan Dalsgaard presented the planned phase II study with C21 in COVID-19.

Sitdown interview with Finwire, Dec 16 2019

Interview with CEO, Carl-Johan Dalsgaard (swedish only)

Avanza börsdag, Nov 19 2019

Company presentation with CEO, Carl-Johan Dalsgaard

Pareto Health Care Conference, Sep 5 2019

Interview with CEO, Carl-Johan Dalsgaard